Literature DB >> 23100197

New hope for survivors of stroke and traumatic brain injury.

Ian Clark1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100197     DOI: 10.1007/s40263-012-0014-1

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  15 in total

1.  3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit.

Authors:  Isabella Russo; Luca Caracciolo; David Tweedie; Sang-Ho Choi; Nigel H Greig; Sergio Barlati; Francesca Bosetti
Journal:  J Neurochem       Date:  2012-07-25       Impact factor: 5.372

2.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration.

Authors:  Liya Qin; Xuefei Wu; Michelle L Block; Yuxin Liu; George R Breese; Jau-Shyong Hong; Darin J Knapp; Fulton T Crews
Journal:  Glia       Date:  2007-04-01       Impact factor: 7.452

3.  THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES.

Authors:  O V Batson
Journal:  Ann Surg       Date:  1940-07       Impact factor: 12.969

4.  Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2011-02       Impact factor: 5.749

5.  Brain-penetrating tumor necrosis factor decoy receptor in the mouse.

Authors:  Qing-Hui Zhou; Ruben J Boado; Eric Ka-Wai Hui; Jeff Zhiqiang Lu; William M Pardridge
Journal:  Drug Metab Dispos       Date:  2010-09-30       Impact factor: 3.922

6.  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients.

Authors:  James W Simpkins; Joshua W Gatson; Jane G Wigginton
Journal:  Alzheimers Dement       Date:  2009-03       Impact factor: 21.566

7.  Protein accumulation in cerebrospinal fluid during -90 degrees head-down tilt in rabbit.

Authors:  T S Wen; D C Randall; J F Zolman
Journal:  J Appl Physiol (1985)       Date:  1994-09

8.  Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra.

Authors:  Vikas Kaushal; Lyanne C Schlichter
Journal:  J Neurosci       Date:  2008-02-27       Impact factor: 6.167

9.  Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice.

Authors:  Tursun Alkam; Atsumi Nitta; Hiroyuki Mizoguchi; Kuniaki Saito; Mitsuru Seshima; Akio Itoh; Kiyofumi Yamada; Toshitaka Nabeshima
Journal:  Behav Brain Res       Date:  2007-12-27       Impact factor: 3.332

10.  Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.

Authors:  Edward L Tobinick; Hyman Gross
Journal:  J Neuroinflammation       Date:  2008-01-09       Impact factor: 8.322

View more
  7 in total

Review 1.  Practice advisory: Etanercept for poststroke disability: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  Gary S Gronseth; Steven R Messé
Journal:  Neurology       Date:  2016-06-07       Impact factor: 9.910

2.  Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.

Authors:  Stephen J Page
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

3.  Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.

Authors:  Tracey A Ignatowski; Robert N Spengler; Krishnan M Dhandapani; Hedy Folkersma; Roger F Butterworth; Edward Tobinick
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

4.  Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.

Authors:  Tracey A Ignatowski; Robert N Spengler; Edward Tobinick
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

Review 5.  Background to new treatments for COVID-19, including its chronicity, through altering elements of the cytokine storm.

Authors:  Ian A Clark
Journal:  Rev Med Virol       Date:  2020-12-24       Impact factor: 11.043

Review 6.  Perispinal Delivery of CNS Drugs.

Authors:  Edward Lewis Tobinick
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

7.  Therapeutic Evaluation of Tumor Necrosis Factor-alpha Antagonist Etanercept against Traumatic Brain Injury in Rats: Ultrastructural, Pathological, and Biochemical Analyses.

Authors:  Askin Esen Hasturk; Emre Cemal Gokce; Erdal Resit Yilmaz; Bahriye Horasanli; Oya Evirgen; Nazli Hayirli; Hilal Gokturk; Imge Erguder; Belgin Can
Journal:  Asian J Neurosurg       Date:  2018 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.